Micrus Endovascular Receives FDA Clearance For Courier Microcatheter

San Jose, CA - Micrus Endovascular Corporation announced receipt of U.S. Food and Drug Administration (FDA) clearance to market its Courier microcatheter line in the United States. This product line is currently marketed in the European Union, having received CE Mark clearance in March 2006. Micrus intends to begin selling this product in the U.S. through its domestic direct sales force immediately.

"This clearance comes on the heels of FDA clearance for our Watusi guidewire platform announced last week," said John Kilcoyne, Micrus Endovascular president and CEO. "The addition of the Courier and Watusi to our U.S. product offering enables us to address a greater percentage of the growing domestic embolic procedure market."

SOURCE: Micrus Endovascular Corporation